pI: 5.4091 |
Length (AA): 594 |
MW (Da): 67708 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 80 | 4xs0 (C) | 496 | 562 | 33.00 | 0.66 | 0.3 | 0.24693 | 0.91 |
28 | 92 | 3v6i (B) | 31 | 99 | 25.00 | 0.98 | 0.08 | 0.353528 | -0.69 |
66 | 580 | 4ycu (A) | 72 | 576 | 62.00 | 0 | 1 | 1.6203 | -0.65 |
67 | 593 | 4up7 (A) | 2 | 575 | 50.00 | 0 | 1 | 1.46631 | -0.33 |
67 | 578 | 5hgq (B) | 5 | 507 | 58.00 | 0 | 1 | 1.44825 | 0.12 |
125 | 213 | 4gla (C) | 20 | 103 | 19.00 | 0 | 0.94 | 0.416932 | -0.7 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126972)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G11710 | Lysyl-tRNA synthetase |
Arabidopsis thaliana | AT3G13490 | Lysyl-tRNA synthetase, class II |
Babesia bovis | BBOV_IV002630 | lysyl-tRNA synthetase |
Brugia malayi | Bm1_16500 | lysyl-tRNA synthetase |
Candida albicans | CaO19.6749 | lysyl-tRNA synthetase |
Candida albicans | CaO19.14041 | lysyl-tRNA synthetase |
Caenorhabditis elegans | CELE_T02G5.9 | Protein KARS-1, isoform C |
Cryptosporidium hominis | Chro.40267 | Kars protein |
Cryptosporidium parvum | cgd4_2370 | lysyl-tRNA synthetase (NOB+tRNA synthetase) |
Chlamydia trachomatis | CT_781 | lysine--tRNA ligase |
Dictyostelium discoideum | DDB_G0286517 | leucyl-tRNA synthetase |
Dictyostelium discoideum | DDB_G0281437 | lysine-tRNA ligase |
Drosophila melanogaster | Dmel_CG12141 | Lysyl-tRNA synthetase |
Escherichia coli | b4129 | lysine tRNA synthetase, inducible |
Escherichia coli | b2890 | lysine tRNA synthetase, constitutive |
Echinococcus granulosus | EgrG_000629500 | lysyl tRNA synthetase |
Entamoeba histolytica | EHI_047810 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000629500 | lysyl tRNA synthetase |
Giardia lamblia | GL50803_16766 | Lysyl-tRNA synthetase |
Homo sapiens | ENSG00000065427 | lysyl-tRNA synthetase |
Leishmania braziliensis | LbrM.15.0260 | lysyl-tRNA synthetase, putative |
Leishmania donovani | LdBPK_150270.1 | lysyl-tRNA synthetase, putative |
Leishmania infantum | LinJ.15.0270 | lysyl-tRNA synthetase, putative |
Leishmania major | LmjF.15.0230 | lysyl-tRNA synthetase, putative |
Leishmania mexicana | LmxM.15.0230 | lysyl-tRNA synthetase, putative |
Loa Loa (eye worm) | LOAG_03217 | hypothetical protein |
Mycobacterium leprae | ML0233 | Probable lysyl-tRNA synthase LysS (lysine--tRNA ligase 1) (LysRS 1) (lysine translase) |
Mycobacterium leprae | ML1393c | Possible lysyl-tRNA synthetase 2 LysX |
Mus musculus | 102642768 | lysine--tRNA ligase-like |
Mus musculus | ENSMUSG00000031948 | lysyl-tRNA synthetase |
Mus musculus | 102641648 | lysine--tRNA ligase-like |
Mycobacterium tuberculosis | Rv3598c | Lysyl-tRNA synthetase 1 LysS (lysine--tRNA ligase 1) (LysRS 1) (lysine translase) |
Mycobacterium tuberculosis | Rv1640c | Lysyl-tRNA synthetase 2 LysX |
Mycobacterium ulcerans | MUL_1626 | lysyl-tRNA synthetase |
Mycobacterium ulcerans | MUL_4181 | lysyl-tRNA synthetase |
Neospora caninum | NCLIV_019960 | lysyl-tRNA synthetase, putative |
Oryza sativa | 4333345 | Os03g0586800 |
Oryza sativa | 4330025 | Os02g0623500 |
Plasmodium berghei | PBANKA_1362900 | lysine--tRNA ligase, putative |
Plasmodium falciparum | PF3D7_1350100 | lysine--tRNA ligase |
Plasmodium knowlesi | PKNH_1250800 | lysine--tRNA ligase, putative |
Plasmodium vivax | PVX_083400 | lysine--tRNA ligase, putative |
Plasmodium yoelii | PY00115 | lysyl-tRNA synthetase |
Saccharomyces cerevisiae | YDR037W | lysine--tRNA ligase KRS1 |
Schistosoma japonicum | Sjp_0010800 | ko:K04567 lysyl-tRNA synthetase, class II, putative |
Schistosoma mansoni | Smp_104470.1 | lysyl-tRNA synthetase |
Schistosoma mansoni | Smp_104470.2 | lysyl-tRNA synthetase |
Schmidtea mediterranea | mk4.038378.01 | |
Schmidtea mediterranea | mk4.001011.00 | LysineALQ-tRNA ligase |
Schmidtea mediterranea | mk4.038378.00 | |
Trypanosoma brucei gambiense | Tbg972.8.1220 | lysyl-tRNA synthetase, putative |
Trypanosoma brucei | Tb927.8.1600 | lysyl-tRNA synthetase, putative |
Trypanosoma congolense | TcIL3000_0_06390 | lysyl-tRNA synthetase, putative |
Trypanosoma cruzi | TcCLB.508971.30 | lysyl-tRNA synthetase, putative |
Toxoplasma gondii | TGME49_205710 | lysine-tRNA ligase |
Theileria parva | TP03_0387 | lysyl-tRNA synthetase, putative |
Trichomonas vaginalis | TVAG_205400 | lysyl-tRNA synthetase, putative |
Trichomonas vaginalis | TVAG_152430 | lysyl-tRNA synthetase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1600 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1600 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1600 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.1600 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2890 | Escherichia coli | essential | goodall |
b4129 | Escherichia coli | non-essential | goodall |
CELE_T02G5.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T02G5.9 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T02G5.9 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T02G5.9 | Caenorhabditis elegans | sterile | wormbase |
YDR037W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_205710 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium falciparum | lysine--tRNA ligase | Compounds | References |
Homo sapiens | lysyl-tRNA synthetase | Compounds | References |